BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 30913144)

  • 21. Long-acting reversible contraception: a review in special populations.
    Prescott GM; Matthews CM
    Pharmacotherapy; 2014 Jan; 34(1):46-59. PubMed ID: 24130075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-acting reversible contraception in adolescents: a systematic review and meta-analysis.
    Diedrich JT; Klein DA; Peipert JF
    Am J Obstet Gynecol; 2017 Apr; 216(4):364.e1-364.e12. PubMed ID: 28038902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-acting Reversible Contraception-Highly Efficacious, Safe, and Underutilized.
    Wu JP; Moniz MH; Ursu AN
    JAMA; 2018 Jul; 320(4):397-398. PubMed ID: 29984374
    [No Abstract]   [Full Text] [Related]  

  • 24. Contraception with the new intrauterine systems: a winning choice if shared!
    di Spiezio Sardo A; Mastantuoni E; De Angelis MC; Zizolfi B
    Minerva Ginecol; 2019 Oct; 71(5):377-384. PubMed ID: 31698892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Latest in Teen Pregnancy Prevention: Long-Acting Reversible Contraception.
    McClellan K; Temples H; Miller L
    J Pediatr Health Care; 2018; 32(5):e91-e97. PubMed ID: 30180941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improving the uptake of long acting reversible contraception: a review.
    Michie L; Cameron ST
    Minerva Ginecol; 2013 Jun; 65(3):241-52. PubMed ID: 23689167
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of controlled release systems over the past 50years in the area of contraception.
    Friend DR
    J Control Release; 2016 Oct; 240():235-241. PubMed ID: 26732558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-Acting Reversible Contraception: An Essential Guide for Pediatric Primary Care Providers.
    Allen S; Barlow E
    Pediatr Clin North Am; 2017 Apr; 64(2):359-369. PubMed ID: 28292451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Acting Reversible Contraception for Adolescents: A Review.
    Francis JKR; Gold MA
    JAMA Pediatr; 2017 Jul; 171(7):694-701. PubMed ID: 28558091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Reversible long-duration contraceptives: an efficient strategy to reduce non-planned pregnancies].
    Lira-Plascencia J; Velázquez-Ramírez N; Ibargüengoitia-Ochoa F; Montoya-Romero Jde J; Castelazo-Morales E; Valerio-Castro E
    Ginecol Obstet Mex; 2013 Sep; 81(9):530-40. PubMed ID: 24187817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of unintended pregnancy: a focus on long-acting reversible contraception.
    Pickle S; Wu J; Burbank-Schmitt E
    Prim Care; 2014 Jun; 41(2):239-60. PubMed ID: 24830607
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Barriers and Facilitators to Adolescents' Use of Long-Acting Reversible Contraceptives.
    Pritt NM; Norris AH; Berlan ED
    J Pediatr Adolesc Gynecol; 2017 Feb; 30(1):18-22. PubMed ID: 27477904
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-acting hormonal contraception.
    Benagiano G; Gabelnick H; Brosens I
    Womens Health (Lond); 2015 Nov; 11(6):749-57. PubMed ID: 26626534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contraceptive needs of the adolescent.
    Steyn PS; Goldstuck ND
    Best Pract Res Clin Obstet Gynaecol; 2014 Aug; 28(6):891-901. PubMed ID: 24947598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Acting Reversible Contraception.
    Curtis KM; Peipert JF
    N Engl J Med; 2017 Feb; 376(5):461-468. PubMed ID: 28146650
    [No Abstract]   [Full Text] [Related]  

  • 37. New developments in long-acting reversible contraception: the promise of intrauterine devices and implants to improve family planning services.
    Turok DK; Gawron LM; Lawson S
    Fertil Steril; 2016 Nov; 106(6):1273-1281. PubMed ID: 27717553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-acting reversible contraception: reducing unintended pregnancies.
    Ruddick C
    Community Pract; 2009 Sep; 82(9):24-7. PubMed ID: 19788120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy.
    Power J; French R; Cowan F
    Cochrane Database Syst Rev; 2007 Jul; 2007(3):CD001326. PubMed ID: 17636668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.
    Mazza D; Bateson D; Frearson M; Goldstone P; Kovacs G; Baber R
    Aust N Z J Obstet Gynaecol; 2017 Apr; 57(2):206-212. PubMed ID: 28294293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.